113 related articles for article (PubMed ID: 10497239)
1. Characterization of the mUBC9-binding sites required for E2A protein degradation.
Huggins GS; Chin MT; Sibinga NE; Lee SL; Haber E; Lee ME
J Biol Chem; 1999 Oct; 274(40):28690-6. PubMed ID: 10497239
[TBL] [Abstract][Full Text] [Related]
2. Degradation of E2A proteins through a ubiquitin-conjugating enzyme, UbcE2A.
Kho CJ; Huggins GS; Endege WO; Hsieh CM; Lee ME; Haber E
J Biol Chem; 1997 Feb; 272(6):3845-51. PubMed ID: 9013644
[TBL] [Abstract][Full Text] [Related]
3. The mUBC9 murine ubiquitin conjugating enzyme interacts with the E2A transcription factors.
Loveys DA; Streiff MB; Schaefer TS; Kato GJ
Gene; 1997 Nov; 201(1-2):169-77. PubMed ID: 9409784
[TBL] [Abstract][Full Text] [Related]
4. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.
Huang Z; Nie L; Xu M; Sun XH
Mol Cell Biol; 2004 Oct; 24(20):8951-62. PubMed ID: 15456869
[TBL] [Abstract][Full Text] [Related]
5. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities.
Nie L; Xu M; Vladimirova A; Sun XH
EMBO J; 2003 Nov; 22(21):5780-92. PubMed ID: 14592976
[TBL] [Abstract][Full Text] [Related]
6. Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription.
Thomas MK; Yao KM; Tenser MS; Wong GG; Habener JF
Mol Cell Biol; 1999 Dec; 19(12):8492-504. PubMed ID: 10567574
[TBL] [Abstract][Full Text] [Related]
7. E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1.
Lingbeck JM; Trausch-Azar JS; Ciechanover A; Schwartz AL
Oncogene; 2005 Sep; 24(42):6376-84. PubMed ID: 16007194
[TBL] [Abstract][Full Text] [Related]
8. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF.
Inukai T; Inaba T; Ikushima S; Look AT
Mol Cell Biol; 1998 Oct; 18(10):6035-43. PubMed ID: 9742120
[TBL] [Abstract][Full Text] [Related]
9. The polymyositis-scleroderma autoantigen interacts with the helix-loop-helix proteins E12 and E47.
Kho CJ; Huggins GS; Endege WO; Patterson C; Jain MK; Lee ME; Haber E
J Biol Chem; 1997 May; 272(20):13426-31. PubMed ID: 9148967
[TBL] [Abstract][Full Text] [Related]
10. E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein.
Loveys DA; Streiff MB; Kato GJ
Nucleic Acids Res; 1996 Jul; 24(14):2813-20. PubMed ID: 8759016
[TBL] [Abstract][Full Text] [Related]
11. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.
Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT
Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688
[TBL] [Abstract][Full Text] [Related]
12. In vivo interactions of MyoD, Id1, and E2A proteins determined by acceptor photobleaching fluorescence resonance energy transfer.
Lingbeck JM; Trausch-Azar JS; Ciechanover A; Schwartz AL
FASEB J; 2008 Jun; 22(6):1694-701. PubMed ID: 18198216
[TBL] [Abstract][Full Text] [Related]
13. Decreased E47 in senescent B cell precursors is stage specific and regulated posttranslationally by protein turnover.
Van der Put E; Frasca D; King AM; Blomberg BB; Riley RL
J Immunol; 2004 Jul; 173(2):818-27. PubMed ID: 15240668
[TBL] [Abstract][Full Text] [Related]
14. Inefficient homooligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding.
Chakraborty T; Brennan TJ; Li L; Edmondson D; Olson EN
Mol Cell Biol; 1991 Jul; 11(7):3633-41. PubMed ID: 1646392
[TBL] [Abstract][Full Text] [Related]
15. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
[TBL] [Abstract][Full Text] [Related]
16. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
Hunger SP; Ohyashiki K; Toyama K; Cleary ML
Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826
[TBL] [Abstract][Full Text] [Related]
17. B-cell-specific DNA binding by an E47 homodimer.
Shen CP; Kadesch T
Mol Cell Biol; 1995 Aug; 15(8):4518-24. PubMed ID: 7623842
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of E47 as a potential determinant of B-cell-specific activity.
Sloan SR; Shen CP; McCarrick-Walmsley R; Kadesch T
Mol Cell Biol; 1996 Dec; 16(12):6900-8. PubMed ID: 8943345
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains.
Nagulapalli S; Atchison ML
Mol Cell Biol; 1998 Aug; 18(8):4639-50. PubMed ID: 9671474
[TBL] [Abstract][Full Text] [Related]
20. mUBC9, a novel adenovirus E1A-interacting protein that complements a yeast cell cycle defect.
Hateboer G; Hijmans EM; Nooij JB; Schlenker S; Jentsch S; Bernards R
J Biol Chem; 1996 Oct; 271(42):25906-11. PubMed ID: 8824223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
